Mosanna Therapeutics AG

https://www.mosanna.com

Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients. *

	Start	2022-07-13 existent
	Industry	MOS-118 (formerly AVE0118, Mosanna Therapeutics / Aventis)
	Industry 2	drug development
	Person	Talbot, Jonathan (Mosanna Therapeutics 202207 CEO + Co-Founder)
	Person 2	Machielse, Ben (Mosanna Therapeutics 202207 Board Chair before Vtesse + Omthera Pharmaceuticals)

	Street	91 Grellingerstr.
	City	4052 Basel
		Address record changed: 2022-07-14

Basic data	Employees	n. a.

		�About Section� taken from web site of organisation on 14.07.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Mosanna Therapeutics AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)